Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
7 Semaglutide 2.4 mg, a glucagon-like peptide-1 receptor agonist, has demonstrated superior efficacy in weight reduction and cardiovascular risk mitigation in the global phase 3 Semaglutide Treatment Effect in People with Obesity (STEP) program
Clinician-prescribed GLP-1 medication like Wegovy, Ozempic, Mounjaro, Foundayo or Zepbound 1:1 personalized video coaching Science-backed learning curriculum Full-service insurance navigation +10% weight loss guaranteed or you're eligible for money back The Metabolic Reset $199/month (3-month commitment required) A 20-minute video clinician visit including lab work review Ongoing access to your Medical and Support Teams Support navigating medication insurance coverage 1:1 video coaching sessions A holistic curriculum focused on food, exercise, sleep, and emotional health Tracking tools and helpful tips via the Calibrate app Prescription GLP-1 Medication Affordable copay with insurance We navigate your insurance on your behalf GLP-1s for most members with commercial insurance should be $25/month or less, after any deductible is met Calibrate Welcome Kit Included Personalized smart scale that connects to the Calibrate app Exclusive Calibrate orientation tools *Lab tests and prescription medications are not included in the membership cost, but well work with your commercial/employer insurance to get them covered
L.JonesD
Clinical Implementation Challenges Healthcare providers face numerous challenges when considering clinical implementation of these peptides
Long neural genes harbor recurrent DNA Break clusters in neural stem/progenitor cells
BPC-157: Why Everyone Is Talking About This Tissue Repair Peptide What Is BPC-157 Peptide and Why Is It Getting So Much Attention
